Found 8 matching trials
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease PHASE3 A study Comparing the Clinical Benefit of Finerenone Versus a Fixed-Dose Co...
Show More Location
Sarfez Pharmaceuticals, Inc.
Learn More & Join Trial
Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects PHASE3 This study examines the bioavailability and bioequivalence of single dose o...
Show More Location
Sarfez Pharmaceuticals
Learn More & Join Trial
A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions: PHASE1 The purpose of this study is to evaluate the bioavailability, safety and to...
Show More Learn More & Join Trial
Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone PHASE3 To study intrasubject variability and steady-state pharmacokinetics of mult...
Show More Location
Sarfez Pharmaceuticals
Learn More & Join Trial
Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions PHASE1 This is an open-labeled (laboratory blinded), randomized, two period, singl...
Show More Location
Private healthcare institution "Clinical Hospital "RZD-Medicine" of the city of Yaroslavl"
Learn More & Join Trial
Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. PHASE4 Study hypothesis is that the time from randomization to the increase of nat...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure PHASE4 The primary objective of this study is to learn whether a morning dose of e...
Show More Location
Future Life Clinical Trials
Learn More & Join Trial
A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) PHASE1 Part I is a 3-period, active comparator-controlled, fixed sequence study to...
Show More Location
Multiple Locations
Learn More & Join Trial